
Gastroenterologist at @MayoClinic with expertise in the diagnosis and treatment of #IBD. Tweets are my own. #MayoClinicFL
Jacksonville Beach, FL
Joined December 2015
- Tweets96
- Following55
- Followers988
- Likes31
Francis (Frank) Farraye, MD, MSc retweeted
Welcome @guthealingg Dr. Sophia Dar to @MayoClinicFLGIH as the 2026-2027 5th Advanced #IBD Fellow
Welcome to the @MayoClinicGIHep family 🧑🧑🧒🧒
@FarrayeIBD @JHashashMD @JGubatanMD
Francis (Frank) Farraye, MD, MSc retweeted
Thank you @DDS_Journal for highlighting our work on BAS & pouchitis
@AlsakarnehSaqr @FarrayeIBD
✅BAS not inferior to abx in nonresponse or early relapse (aOR=0.94, p=0.34)
✅ BAS ⬇️ recurrent pouchitis (aHR: 0.57; p<0.001) and ⬆️ time to recurrent
pouchitis (p<0.001)
Alsakarneh et al retrospectively studied the response of patients with pouchitis and resulting from IBD surgery, finding that treatment with bile acid sequestrants was noninferior or possibly superior to the current standard, antibiotic treatment. bit.ly/4mUEVoz
Francis (Frank) Farraye, MD, MSc retweeted
Our #IBD group is growing under @FarrayeIBD leadership
Welcome Dr. John Gubatan @JGubatanMD joining @MayoClinicFLGIH family from Standford where he served as #IBD faculty
Francis (Frank) Farraye, MD, MSc retweeted
Gaining the Upper Hand – Upadacitinib for Crohn’s Disease with Ileostomy: A Real-World Gap Addressed. rdcu.be/eARJX . My invited commentary on doi.org/10.1007/s10620-025-0…, just published in @DDS_Journal. @LaurenLoebMD @FarrayeIBD @EdwardLoftus2 @ibdgijami @JHashashMD
Francis (Frank) Farraye, MD, MSc retweeted
Join us for our 2nd @Mayoclinic #IBD Conference in ☀️🏖️ Florida 🐊 @MayoClinicFLGIH
📍Mayo FL
🗓️ Saturday, Nov 8
💻 Virtual option available
➕🩻 bonus Friday session with ✋🤚 on IUS session
📝👉 tinyurl.com/3emuhwpv
@FarrayeIBD @ibdgijami @JGubatanMD @CrohnsColitisFn
Francis (Frank) Farraye, MD, MSc retweeted
🩺💉 New @AmCollegeGastro guideline urges GI docs to promote preventive care — like vaccines & screenings — for #IBD patients.
Many patients see their GI as a de facto #PrimaryCare provider, say @FarrayeIBD & colleagues. #PreventiveCare #GITwitter
bit.ly/44tkyHv
Francis (Frank) Farraye, MD, MSc retweeted
Patients with Crohn’s Disease and Ileostomy Can Respond to Upadacitinib | Digestive Diseases and Sciences @LaurenLoebMD @ibdgijami @ibdgijami @JHashashMD @FarrayeIBD link.springer.com/article/10…
Francis (Frank) Farraye, MD, MSc retweeted
Such a pleasure to host Francis A. Farraye, MD, MSc, today for GI Grand Rounds as we celebrated our fourth annual Peppercorn Lectureship, named for Dr. Mark Peppercorn! We all enjoyed learning from Dr. Farraye's talk, "Health Maintenance for Patients with IBD." 🌟
Francis (Frank) Farraye, MD, MSc retweeted
Hot of the press 🚨
Just published in @APandT our study on risk of new onset #IBD in patients taking IL-17 inhibitors 💊
🔑 findings:
📌 Patients on anti-IL-17 are at increased risk of de novo IBD (aHR: 2.5)
📌 Risk was elevated for both UC and CD
📌Number needed to harm (NNH=161)
📌Secukinumab was associated with highest risk (aHR=2.82)
Full 📖: onlinelibrary.wiley.com/doi/……
@FarrayeIBD @JHashashMD @OmarAlTaanii @RazanAburummann @AmCollegeGastro @AmerGastroAssn @CrohnsColitisFn @ACPIMPhysicians @ACRheum
#GITwitter #MedTwitter
Francis (Frank) Farraye, MD, MSc retweeted
Incredibly high yield topic on everyday IBD in terms of things to monitor in patients with IBD! @DCharabaty @FarrayeIBD @PDulaiMD @IBDConference #AIBD2024
Francis (Frank) Farraye, MD, MSc retweeted
🔥New article published in @AmJGastro
📈 IBD incidence is surging disproportionately affecting females and the elderly
⬆️ 75% of countries report rising incidence rates
shorturl.at/GL4pn
@FarrayeIBD @KarnJUVE @Siew_C_Ng @RashidLui @GKochharMD
@ChawinthornV @ttuhscmed
Francis (Frank) Farraye, MD, MSc retweeted
💡 Key Question: Are patients with IBD at higher risk for shingles complications? (Spoiler: Yes!)
📊 What We Found: IBD patients had 15.52% complication rate vs 12.51% in non-IBD controls (p<0.0001) 4/12
@IBDProNews @CrohnsColitisFn @FarrayeIBD
Francis (Frank) Farraye, MD, MSc retweeted
New Clinical Practice Update in @AGA_CGH by Drs. Anna M. Buchner, @MariettaIacucci, and @FarrayeIBD explores using endoscopic scoring systems for mucosal healing for patients with #IBD, including ulcerative colitis and #Crohn's disease.
🔗Learn more: ow.ly/WawU50U7b8W
Francis (Frank) Farraye, MD, MSc retweeted
#IBD patients want to know…
What they can do in addition to starting effective medical therapy for their inflammation
🚭 avoid smoking
🍽️Diet: Mediterranean diet 🍆🥑🍓🥦
🚫NSAID
🎯Normal BMI
🏃🏽♀️Get active
😊Focus on mental health
👶Discuss contraception
@AshwinMDIBD
Francis (Frank) Farraye, MD, MSc retweeted
Save the date!! Sept 28, 2024! For Updates in IBD conference @MayoClinic FL
Great topics
Amazing speakers
Sun and Fun
Sign up ce.mayo.edu/ibd2024
@AmCollegeGastro @AmerGastroAssn @CrohnsColitisFn @IBDProNews @FarrayeIBD @ibdgijami @EdwardLoftus2 @MLongMD @Khanna_S @IBDMD
Francis (Frank) Farraye, MD, MSc retweeted
Great work coming from the #IBD groups at @MayoClinicFLGIH @AHNGastro in collaboration in @APandT
@akMD03 @JessPetrovMD @FarrayeIBD @JHashashMD @GKochharMD
🔥 topic #GLP1 in #IBD ➡️ no difference in steroid use but ⬇️ risk of surgery in #CD and #UC
rb.gy/591zna
Francis (Frank) Farraye, MD, MSc retweeted
Join us for Mayo Clinic Updates in Inflammatory Bowel Disease 2024
Updates in the diagnosis + management of #IBD & related complications
Open to physicians, APPs, nurses, pharmacists, learners
Sept 28 7AM-6PM
Mayo Clinic Florida
Jacksonville, Florida
Visit ce.mayo.edu/ibd2024 for details and registration
Francis (Frank) Farraye, MD, MSc retweeted
🔎 ACG Case Reports Journal 🔍
Sirolimus Use in Refractory Crohn's Disease
Siu, et al.
👉 bit.ly/45Clnh7
@RSiuMD @ChristianKarime @JHashashMD @ibdgijami @FarrayeIBD @KhushbooSGala @VibhuC_MD #GIfellows
Francis (Frank) Farraye, MD, MSc retweeted
Join @FarrayeIBD and @MLongMD as we discuss the Best of ECCO Part 3. IBD Drive Time: The Best of ECCO WIth Dr Frank Farraye hmpgloballearningnetwork.com…
Francis (Frank) Farraye, MD, MSc retweeted
Patients with Inflammatory Bowel Disease are at Increased Risk for Hospitalization due to RSV: Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/abstrac…
@Ryansmith_MD @FarrayeIBD @akMD03 @AmJGastro @ACG @CrohnsColitisFn @AmerGastroAssn




































